Tag Archives: Clinical diversity

FDA Recommendations for Promoting Diversity in Clinical Trial Enrollment 

Over the past few decades, the United States Food and Drug Administration (FDA) has been actively working to promote inclusive enrollment practices aimed at making clinical trials more reflective of the general population; they have also focused on including a larger proportion of demographics most likely to use the medications if approved. Despite broadening eligibility criteria, challenges to participation in clinical trials remain as does widespread under-representation of several racial demographics. 

Continue reading

Please follow and like us: